In the phase 3 CORALreef Lipids trial, the oral PCSK9 inhibitor enlicitide reduced LDL cholesterol by 57% at 24 weeks and also lowered non HDL cholesterol, apolipoprotein B, and lipoprotein(a). Adverse events were Liposomal Glutathione Fullscript Liposomal Glutathione Capsules, 30ct Remedy Holistic Pure Encapsulations Liposomal Glutathione Shop Now The Healthy Place In the phase 3 CORALreef Lipids trial, the oral PCSK9 inhibitor enlicitide reduced LDL cholesterol by 57% at 24 weeks and also lowered non HDL cholesterol, apolipoprotein B, and lipoprotein(a). Adverse events were Orthoplex White Liposomal Glutathione 50g